As accessible health care providers, pharmacists can raise awareness about the proper use of OTC blood glucose meters and continuous glucose monitoring devices.
|Articles|July 30, 2021
- July 2021
- Volume 87
- Issue 7
July 2021 Interactives: Pet Peeves
Penny pinchers, early arrivals, and more are featured in this month's Pet Peeves.
Advertisement
Penny Pincher: Patient copay is $1 but they want you to try GoodRx.
Early Arrival: Patient asks for a transfer, you say 1 hour and they arrive in 15 minutes.
New Year, New Insurance: New year but "I have the same insurance" yet they did get a card in the mail...
What's bothering you? Bossy patients, abandoned prescriptions, drive-through demands? We want to know! Send your pet peeves to cmollison@pharmacytimes.com. We'll share them here and in the publication.
Articles in this issue
about 5 years ago
OTC Product News: July 2021about 5 years ago
Rx Product News: July 2021about 5 years ago
Labeling and Packaging Issues Contribute to Dose, Quantity Errorsabout 5 years ago
Study: Women With CAD, Heart Disease Often Go Undertreatedabout 5 years ago
How Does the EUA for the COVID-19 Vaccines Work?about 5 years ago
Lifestyle Changes Can Improve Inflammatory Burdenabout 5 years ago
Patients With Epilepsy Are Skeptical About Generic Antiseizure Drugsabout 5 years ago
Training Program Helps Pharmacists Provide Diabetes Careabout 5 years ago
July 2021 Interactives: Case StudiesNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
SubscribeAdvertisement
Related to this article
Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
As earning years peak, so do spending and responsibility—here’s where midcareer pharmacists should focus their financial decision-making.
Despite the controversy surrounding mRNA's role in the COVID-19 response, the technology's broader promise—to prevent, treat, and even cure a host of diseases—is coming into focus.
The first AHA endocarditis update in 11 years expands outpatient options, with a bigger role for pharmacists.
A suspected plague death in Russia has renewed attention on the rare infection. Here's how to spot pneumonic plague, and which antibiotics the CDC recommends.
A meta-analysis of 27 trials found 15% lower cardiovascular (CV) event risk per 10-mm Hg SBP reduction, with eGFR declines but no rise in kidney failure.
In the phase 2 ZUPREME 1 trial, the once-weekly amylin analog was well tolerated, with nausea mostly mild and limited to dose escalation.
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Value of Self-Monitoring Blood Glucose Tools in Preventing and Reducing Prediabetes and Diabetes-Related Complications
2
Rising Gallbladder Complications With GLP-1 Receptor Agonists Call for Closer Pharmacist Monitoring
3
Patients Report Early, Sustained Functional Gains With First-Line Zongertinib in HER2-Mutant NSCLC
4
What Different Communities Taught Me About Patient Care
5